期刊文献+

低蛋白饮食联合α-酮酸对以轻度蛋白尿为主的原发性肾小球肾炎预后临床研究 被引量:2

Clinical Study of Low-protein Diet Combined with α-keto Acid on the Prognosis of Primary Glomerulonephritis with Mild Proteinuria
下载PDF
导出
摘要 目的:初步探讨低蛋白饮食联合α-酮酸能否改善以轻度蛋白尿为主的原发性肾小球肾炎患者的临床意义。方法:40例以轻度蛋白尿为主的原发性肾小球肾炎患者分为治疗组和对照组,其中治疗组20例,接受低蛋白饮食联合α-酮酸和常规治疗;对照组20例,接受低蛋白饮食和常规治疗。观察两组患者尿蛋白量下降、蛋白尿转阴率及中等量以上蛋白尿率。结果:(1)两组病例入选时基线资料可比性好(P>0.05);(2)在现有条件下失访率不超过5%;(3)治疗组尿蛋白量显著减少[(0.45±0.23)g/24hvs.(0.91±0.35)g/24h,P<0.05)];中等量蛋白尿终点事件发生率显著低(P<0.05)。结论:低蛋白饮食联合α-酮酸能改善以轻度蛋白尿为主的原发性肾小球肾炎的尿蛋白量。 Objective :To investigate whether low - protein diet combined with α - keto acid can improve the prognosis of primary glomerulonephritis with mild proteinuriao Methods:40 patients were randomly assigned to treatment and control groups. Treatment group(20 cases) received low -protein diet combined with α -keto acid and conventional treatment; control group(20 cases) received alow protein diet and conventional treatment. The primary efficacy judgment indicators: (1) the amount of urinary protein ; (2) the rate of proteinuria was negative and moderate amount of proteinuria. Results: ( 1 ) Baseline data were comparable in the two groups (P 〉 0.05) ; (2) Under existing conditions, the dropout rate does not exceed 5 % ; (3) urinary protein of treatment group significantly reduced [ (0.45 ± 0.23 ) g/24 h vs. (0.91 ± 0.35 ) g/24 h, P 〈 0.05 ) ; moderate amount of proteinuria endpoint events were significantly low ( P 〈 0.05 ). Conclusion: The study shown that low - protein diet combined with α - keto acid can reduce urinary protein of primary glomenrulonephritis with mild proteinuria.
出处 《中国中西医结合肾病杂志》 2012年第10期879-882,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 低蛋白饮食 Α-酮酸 原发性肾小球肾炎 随机对照试验 Low -protein diet α -keto acid Primary glomemlonephritis Randomized controlled trials
  • 相关文献

参考文献18

  • 1National Kidney Foundation-K/DOQI. Clincal Practice Guide- lines for chronic kidney disease, eveluation classification and stratification. Am J Kidney Dis 2002,39( suppl 1 ) :S1 -S266.
  • 2Alfrey AC, Froment DH, Hammond WS. Role of iron in the tubu- lo - interstitial injury in nephrotoxin serum nephritis. Kidney Int, 1989,36 (5) :753 - 759.
  • 3. Matsuo S, Morita Y, Mizuno M, et al. Proteinuria and damage to tubular cells-is complement a culprit? Nephrol Dial Transplant, 1998,13 ( 11 ) :2723 - 2726.
  • 4Aparacio M, Potaux J, Bouchet JL, et al. Proteinuria and progres- sion of renal failure in patients on a low - protein diet. Nephron, 1989,51 (12) :292 - 293.
  • 5Peters H, Border WA, Noble NA. Angiotensin II blockade and low- protein diet produce additive therapeutic effects in experi- mental glomerulonephritis. Kidney Int, 2000, 57 ( 4 ) : 1493 - 1501.
  • 6梅小斌,袁伟杰,郭志勇,李保春,于建平,吴灏,邹大进,高从容,曹翔,崔若兰.α-酮酸配伍低蛋白饮食对早期2型糖尿病肾病的影响[J].第二军医大学学报,2004,25(5):530-533. 被引量:10
  • 7Teplan V ,Schuek 0 , Horackova M , et al. Effect of a keto aci- damino acid supplement on the metabolism and renal elimination of branched-chain acids in patients with chronic renal insuffi- ciency on a low protein diet. Wien Klin Wochenschr,2000, 112 (20) :876 -881.
  • 8Walser M , Hill S. Can renal replacement be deferred by a sup- plemented very low protein diet? J Am Soc Nephrol, 1999,10 (1) :110-116.
  • 9Aparieio M , Chauveau P, De Pr6cigout V, et al. Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. JAm Soc Nephrol,2000,11 (4) :708 -716.
  • 10Levey AS, Greene T, Beck GJ, et al. Dietary protein restriction and the progression of chronic renal disease:what have all of the results of the MDRD study shown? Modification of Diet in Benal Disease Study group. J Am Soc Nephrel, 1999,10 ( 11 ) : 2426 - 2439.

二级参考文献30

  • 1韩庆烽,董捷,汪涛.腹膜透析病人营养不良发生机制的初步探讨[J].营养学报,2004,26(5):358-361. 被引量:30
  • 2李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 3Lacy JA. Albumin overview: use as a nutritional marker and as a therapeutic intervention [J]. Crit Care Nurse,1991,11(1): 46-49.
  • 4Denis R B. Laboratory tests and nutritional assessment[J]. Pediatr Clin North Am,1989,36(2):139-161.
  • 5[1]Barsotti G,Cupisti A,Morelli E,et al.Secondary hyperparathyroidism in severe chronic renal failure is corrected by very-low dietary phosphate intake and calcium carbonate supplementation[J].Nephron,1998,79(2):137-141.
  • 6[2]Biolo G,Toigo G,Ciocchi B,et al.Relationship between whole-body protein turnover and serum creatinine in chronically uremic patients[J].Miner Electrolyte Metab,1998,24(4):267-272.
  • 7[3]Walser M,Hill S.Can renal replacement be deferred by a supplemented very low protein diet[J]?J Am Soc Nephrol,1999,10(1):110-116.
  • 8[4]Macia M,Coronel F,Navarro J F,et al.Calcium salts of keto-amino acids,a phosphate binder alternative for patients on CAPD[J].Clin Nephrol,1997,48(3):181-184.
  • 9[5]Lindenau K,Kokot F,Vetter K,et al.Influence of keto acid(KA)therapeutic on renal osteodystrophy infusionstherapie[J].Nephron,1987,14(Suppl 5):40-42.
  • 10[6]Rigalleau V,Aparicio M,Gin H,et al.Effects of low-protein diet on carbohydrate metabolism and energy expenditure[J].J Ren Nut,1998,8(4):175-178.

共引文献30

同被引文献22

  • 1Menon V,Kopple JD,Wang X,et al. Effect of a very low- protein diet on outcomes: Long-term follow-up of the modification of diet in renal disease (MDRD)study[J]. Am J Kidney Dis, 2009,53 (1) : 208-217.
  • 2Gao X,Wu J,Dong Z,et al. A low-protein diet supple- mented with ketoaeids plays a more protective role againstoxidative stress of rat kidney tissue with 5/6 nephrectomy than a low-protein diet alone[J]. Br J Nutr,2010,103(7) :60.
  • 3Workeneh BT, Mitch WE. Review of muscle wasting asso- ciated with chronic kidney disease[J]. Am J Clin Nutr, 2010, 91 (5) : 1128S-1132S.
  • 4Mahmood N,Junejo AM,Jamal Q,et al. Association of visfatin with chronic kidney disease in a cohort of patients with and without diabetes[J]. J Pak Med Assoc,2010,60( 11 ) : 922-926.
  • 5Gane EJ,Deray G,LiawYF,et al. Telbivudine improves renal function in patients with chronic hepatitis B[J]. Gastroen- terology ,2014,141 ( 1 ) : 138-146.
  • 6Tong MJ,Pan CQ,Harm HW,et al. The management of chronic hepatitis Bin Asian Americans[J]. Dig Dis Sci,2011, 56(4) :3143-3162.
  • 7Mauss S,Berger F,Filmann N,et al. Effect of HBVpoly- merase inhibitors onrenal function in patientswith chron- ic hepatitis B[J]. J Hepatol,2011,55(6) : 1235-1240.
  • 8Marcellin P,Heatheote EJ,Corsa A,et al. No detectable resistance to tenofovir disoproxil fumarate(TDF) following up to 240 weeks of treatment in patients with HBeAg + and HBeAg-chronic hepatitis B virus infection[J]. Hepa- tology, 2011,4 ( 11 ) : 238.
  • 9Mederacke I,Yurdaydin C,Grohennig A,et al. Renal function during treatment with adefovir plus peginterfer- on alfa-2a vs either drug alone in hepatitis B/D co-in- fection[J]. J Viral Hepat, 2012, 19(6) : 387-395.
  • 10ZhuY, YeX,Zhu B, et al. Comparisons between the 2012 new CKD-EPI (Chronic kidney disease epidemiology col laboration)equations and other four approved equations[J]. PLoS One, 2014,9(1) : e84688.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部